News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Conference News ESC 2023 ESC Focused Update on HF Synthesizes New Trial Data for Practical Use L.A. McKeown September 01, 2023
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News HRS 2019 ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost? Todd Neale May 10, 2019
News Conference News EuroPCR 2014 SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings Yael L. Maxwell May 22, 2014
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014
News Conference News AHA 2013 Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients Jason Kahn November 17, 2013